ADCYAP1 and migraine disorder: Thus, cilostazol leads to activation of the pathway that is further downstream than CGRP and PACAP (Fig. 1), and has a high success-rate to induce migraine-like attacks in 86% of adult patients with migraine without aura [116, 120, 125, 126], but also in healthy individuals [121].